GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Medigen Vaccine Biologics rises 2.10% in Wednesday's session

Published by Global Banking & Finance Review

Posted on November 4, 2026

1 min read
Add as preferred source on Google
6547.TWO 48.60 +2.10% last traded price, 4 Nov 2026
Previous close
47.60
Market cap
—

The figures in this article were checked against this snapshot before publication.

Medigen Vaccine Biologics on the Taiwan market saw its shares last traded 2.10% above their previous close at 48.60 TWD on 4 November 2026. The shares moved from a previous close of 47.60 TWD in the Health Care sector.

Last traded price48.60 TWD
Previous close47.60 TWD
Change from the previous close+2.10%

Prices of Medigen Vaccine Biologics (6547.TWO), listed in Taiwan, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 4 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 3 November 2026. We report a stock the day it ends a session 2% or more away from its previous close, where at least 100,000 shares traded in the previous session. How we compile these reports.

Medigen Vaccine Biologics — daily TPEX:6547

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Medigen Vaccine Biologics on TradingView ↗

Related Articles

More from Markets

Explore more articles in the Markets category